Latest News

Kainos Group PLC (LSE:KNOS), the UK-headquartered information technology provider, anticipates delivering annual revenue and adjusted profit before tax comfortably ahead of market expectations. This u

I'm reiterating Pagaya Technologies as a Strong Buy, with the price target adjusted to $67 due to higher share count and net debt. Q2 2026 results validate PGY's AI-driven lending platform, showing 33

Uber COO Andrew Macdonald thinks it's possible the ride-hailing company will have fewer employees in five years. Macdonald said AI could augment and potentially replace some roles.

StoneCo reported weak Q2 results, with revenue up only 2.5% YoY and EPS missing expectations. The company is shifting toward credit to sustain growth, but rising delinquencies raise concerns about rev

Most leading US publicly traded managed care insurers raised their full-year earnings estimates following second quarter results, despite increasing medical costs and membership attrition. Many of the

Zoetis is navigating the worst drawdown in its stock history, driven by weakening U.S. vet clinic traffic and heightened competition across key companion animal franchises. Despite aggressive competit

Rhythm Pharmaceuticals is transitioning from a single rare disease drug to a broad MC4R therapeutic franchise, leveraging multiple formulations for market segmentation. IMCIVREE's AHO approval and ove

LARRY KUDLOW: Trump and the GOP Actually Have a Strong Election Message as Long as They Make It

Astera Labs is evolving from a point-product vendor to an AI fabric platform, driving higher content per accelerator and platform stickiness. I rate ALAB a buy with 15-20% upside, justified by rapid r

Sea Limited is structurally undervalued, with an 18% upside to my $141/share fair value estimate. SE's diversified model—Shopee, Monee, and Garena—drives sustainable growth, with 32%+ five-year revenu

Ahold Delhaize is a leading global grocery retailer offering stable, counter-cyclical returns through dividends, buybacks, and steady growth. ADRNY's fair valuation reflects a forward P/E of 11.4x, wi

Tenaya Therapeutics NASDAQ: TNYA expects to provide regulatory and development updates in the fourth quarter for its two cardiac gene therapy programs and its small-molecule candidate TN-301, Chief Fi

NXG Cushing Midstream Energy Fund remains a buy, with distributions well supported by recent net realized gains and NAV growth. SRV offers a 12.5% yield, recently raised by 11%, but relies heavily on

While all investment markets are predictive by nature, gold and bonds are the most sensitive in sniffing out market imbalances and the sometimes-volatile rebalancings ahead. Gold broke out of the pric

Frasers Group PLC (LSE:FRAS), the British retail group, has built its ownership in Hugo Boss, the German fashion business, to 47.89% following the conclusion of its takeover offer. The company confirm

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Google has won a bankruptcy auction for a large collection of Spirit Airlines' internal business data and software, agreeing to pay $10 million for assets it plans to use in product development and ar

Tonix Pharmaceuticals NASDAQ: TNXP is focusing its near-term strategy on the commercial launch of TONMYA for fibromyalgia while advancing development programs in Lyme disease prevention and major depr

SRG Global Limited (SRGGF) Q4 2026 Earnings Call Transcript

Toll Brothers, Inc. (NYSE:TOL) will release its third quarter earnings report after the closing bell on Tuesday, Aug. 18.